Cart
sales@molnova.com
Inulin
CAS No. 9005-80-5
Inulin( —— )
Catalog No. M19244 CAS No. 9005-80-5
Inulin(Inulin and sodium chloride), a starch found in the tubers and roots of many plants. Since it is hydrolyzable to fructose, it is classified as a fructosan.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 100MG | 38 | In Stock |
|
| 200MG | 52 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameInulin
-
NoteResearch use only, not for human use.
-
Brief DescriptionInulin(Inulin and sodium chloride), a starch found in the tubers and roots of many plants. Since it is hydrolyzable to fructose, it is classified as a fructosan.
-
DescriptionInulin(Inulin and sodium chloride), a starch found in the tubers and roots of many plants. Since it is hydrolyzable to fructose, it is classified as a fructosan.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayAutophagy
-
TargetCXCR
-
RecptorOthers
-
Research AreaOthers-Field
-
Indication——
Chemical Information
-
CAS Number9005-80-5
-
Formula Weight——
-
Molecular FormulaC6nH10n+2O5n+1
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL
-
SMILESO[C@@H]1[C@H](O[C@@H]([C@@H]([C@H]1O)O)O[C@@]2(O[C@H](CO)[C@@H](O)[C@@H]2O)CO[C@]3([C@@H](O)[C@H](O)[C@@H](CO)O3)CO)O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Roberfroid MB, et al. J Nutr, 1998, 128(1), 11-19.
molnova catalog
related products
-
ALX 40-4C
ALX40-4C is a small peptide inhibitor of the chemokine receptor CXCR4 that can inhibit X4 strains of HIV-1.
-
AMG 487
AMG 487 prevents the chemokines I-IP-10 and I-ITAC from binding to CXCR3.?In the cellular assays, AMG 487 inhibits CXCR3-mediated cell migration with IC50 values of 8nM, 15nM and 36nM for I-IP-10, I-ITAC and MIG, respectively.
-
Ulocuplumab
Ulocuplumab (BMS-936564) is a fully human anti-CXCR4 IgG4 antibody.Ulocplumab exhibits antitumor activity in acute myeloid leukemia (AML), non-Hodgkin's lymphoma (NHL), and multiple myeloma transplantation models.
